Austrian Wearable Cardioverter Defibrillator Registry

Sponsor

Medical University of Graz (Other)

Overall Status

Recruiting

CT.gov ID

NCT02816047

Collaborator

(none)

450

Enrollment

Location

Duration (Months)

5.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI <40days, recent PCI/CABG < 3months etc.).

Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.

Condition or Disease	Intervention/Treatment	Phase
Heart Failure Ventricular Dysfunction Sudden Death Sudden Cardiac Arrest Ventricular Tachycardia Ventricular Fibrillation	Other: Registry

Detailed Description

Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients

Study Design

Study Type:

Observational

Anticipated Enrollment :

450 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry

Study Start Date :

Nov 1, 2014

Anticipated Primary Completion Date :

Dec 1, 2021

Anticipated Study Completion Date :

Mar 1, 2022

Outcome Measures

Primary Outcome Measures

Number of participants treated with WCD-treated ventricular arrhythmias [during WCD wearing period; average of 1 year]
Number of participants treated with WCD-treated ventricular arrhythmias